Birdwatch Note
2024-08-17 14:00:44 UTC - NOT_MISLEADING
Posters have a point. Harris does speak about tax-funded R&D patents but conflates them with a very old drug, insulin, and wraps it up in a price-control scheme. NNN. https://www.c-span.org/video/?466668-1/kamala-harris-meets-voters-muscatine-iowa
Written by 59C163F851FAB7C30A0AA96E8009DC52628D5790F8EB3105AF59581EC3FD0E8A
Participant Details
Original Tweet
Tweet embedding is no longer reliably available, due to the platform's instability (in terms of both technology and policy). If the Tweet still exists, you can view it here: https://twitter.com/foo_bar/status/1824612435375878439
Please note, though, that you may need to have your own Twitter account to access that page. I am currently exploring options for archiving Tweet data in a post-API context.
All Information
- ID - 1824808586062581912
- noteId - 1824808586062581912
- participantId -
- noteAuthorParticipantId - 59C163F851FAB7C30A0AA96E8009DC52628D5790F8EB3105AF59581EC3FD0E8A Participant Details
- createdAtMillis - 1723903244878
- tweetId - 1824612435375878439
- classification - NOT_MISLEADING
- believable -
- harmful -
- validationDifficulty -
- misleadingOther - 0
- misleadingFactualError - 0
- misleadingManipulatedMedia - 0
- misleadingOutdatedInformation - 0
- misleadingMissingImportantContext - 0
- misleadingUnverifiedClaimAsFact - 0
- misleadingSatire - 0
- notMisleadingOther - 1
- notMisleadingFactuallyCorrect - 0
- notMisleadingOutdatedButNotWhenWritten - 0
- notMisleadingClearlySatire - 0
- notMisleadingPersonalOpinion - 0
- trustworthySources - 1
- summary
- Posters have a point. Harris does speak about tax-funded R&D patents but conflates them with a very old drug, insulin, and wraps it up in a price-control scheme. NNN. https://www.c-span.org/video/?466668-1/kamala-harris-meets-voters-muscatine-iowa
Note Ratings
| rated at | rated by | |
| 2024-08-22 00:55:44 -0500 | Rating Details | |
| 2024-08-20 08:43:35 -0500 | Rating Details | |
| 2024-08-18 16:14:54 -0500 | Rating Details | |
| 2024-08-18 15:34:59 -0500 | Rating Details | |
| 2024-08-18 13:17:59 -0500 | Rating Details | |
| 2024-08-18 03:55:12 -0500 | Rating Details | |
| 2024-08-18 03:08:03 -0500 | Rating Details | |
| 2024-08-18 00:24:52 -0500 | Rating Details | |
| 2024-08-17 23:02:15 -0500 | Rating Details | |
| 2024-08-17 21:17:40 -0500 | Rating Details | |
| 2024-08-17 21:15:29 -0500 | Rating Details | |
| 2024-08-17 18:55:42 -0500 | Rating Details | |
| 2024-08-17 16:05:59 -0500 | Rating Details | |
| 2024-08-17 15:26:57 -0500 | Rating Details | |
| 2024-08-17 14:09:17 -0500 | Rating Details | |
| 2024-08-17 13:30:40 -0500 | Rating Details | |
| 2024-08-17 13:15:54 -0500 | Rating Details | |
| 2024-08-17 13:06:53 -0500 | Rating Details | |
| 2024-08-17 11:59:18 -0500 | Rating Details | |
| 2024-08-17 11:47:55 -0500 | Rating Details | |
| 2024-08-17 11:44:20 -0500 | Rating Details | |
| 2024-08-17 11:27:09 -0500 | Rating Details | |
| 2024-08-17 10:52:00 -0500 | Rating Details | |
| 2024-08-17 10:50:19 -0500 | Rating Details | |
| 2024-08-17 10:46:33 -0500 | Rating Details | |
| 2024-08-17 10:38:28 -0500 | Rating Details | |
| 2024-08-17 10:36:52 -0500 | Rating Details | |
| 2024-08-17 10:17:09 -0500 | Rating Details | |
| 2024-08-17 09:53:06 -0500 | Rating Details | |
| 2024-08-17 09:50:13 -0500 | Rating Details | |
| 2024-08-17 09:33:54 -0500 | Rating Details | |
| 2024-08-17 09:30:21 -0500 | Rating Details | |
| 2024-08-17 09:10:54 -0500 | Rating Details | |
| 2024-08-17 09:09:46 -0500 | Rating Details | |
| 2024-08-17 09:08:42 -0500 | Rating Details | |
| 2024-08-17 09:06:41 -0500 | Rating Details | |
| 2024-08-17 09:05:37 -0500 | Rating Details | |
| 2024-08-20 17:30:21 -0500 | Rating Details | |
| 2024-08-17 23:23:26 -0500 | Rating Details | |
| 2024-08-17 22:58:26 -0500 | Rating Details | |
| 2024-08-17 19:50:35 -0500 | Rating Details | |
| 2024-08-17 19:21:42 -0500 | Rating Details | |
| 2024-08-17 18:47:44 -0500 | Rating Details | |
| 2024-08-17 16:13:12 -0500 | Rating Details | |
| 2024-08-17 13:45:26 -0500 | Rating Details | |
| 2024-08-17 12:12:47 -0500 | Rating Details | |
| 2024-08-17 11:54:32 -0500 | Rating Details | |
| 2024-08-17 11:53:43 -0500 | Rating Details | |
| 2024-08-17 10:52:02 -0500 | Rating Details | |
| 2024-08-17 10:34:04 -0500 | Rating Details | |
| 2024-08-17 10:08:58 -0500 | Rating Details | |
| 2024-09-07 17:30:50 -0500 | Rating Details | |
| 2024-10-17 18:53:22 -0500 | Rating Details | |
| 2024-12-01 10:34:52 -0600 | Rating Details | |
| 2024-11-26 10:41:48 -0600 | Rating Details |